Cognex - CGNX Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 2 sell ratings, 5 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CGNX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGNX, but not buy additional shares or sell existing shares.
View CGNX analyst ratings or view top-rated stocks.

11 Wall Street research analysts have issued 1 year price objectives for Cognex's shares. Their CGNX share price forecasts range from $40.00 to $80.00. On average, they anticipate the company's share price to reach $52.92 in the next year. This suggests a possible upside of 4.2% from the stock's current price.
View analysts price targets for CGNX or view top-rated stocks among Wall Street analysts.

Cognex's stock was trading at $77.76 on January 1st, 2022. Since then, CGNX shares have decreased by 34.7% and is now trading at $50.76.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our CGNX earnings forecast.

Cognex Co. (NASDAQ:CGNX) issued its quarterly earnings data on Thursday, November, 4th. The scientific and technical instruments company reported $0.40 earnings per share for the quarter, missing the consensus estimate of $0.41 by $0.01. The scientific and technical instruments company had revenue of $284.85 million for the quarter, compared to analyst estimates of $288.32 million. Cognex had a trailing twelve-month return on equity of 16.89% and a net margin of 21.15%. The business's quarterly revenue was up 13.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.49 earnings per share.

Cognex declared a quarterly dividend on Thursday, November 3rd. Stockholders of record on Friday, November 18th will be given a dividend of $0.07 per share on Friday, December 2nd. This represents a $0.28 annualized dividend and a yield of 0.55%. The ex-dividend date is Thursday, November 17th. This is a boost from the stock's previous quarterly dividend of $0.07.
Read our dividend analysis for CGNX.

Cognex (NASDAQ:CGNX) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.55%. The company has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 23.14%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CGNX will have a dividend payout ratio of 24.35% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CGNX.

Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly created shares were distributed to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Cognex issued an update on its fourth quarter 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $235.00 million-$255.00 million, compared to the consensus revenue estimate of $226.23 million.

94 employees have rated Cognex Chief Executive Officer Robert Willett on Glassdoor.com. Robert Willett has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognex investors own include NVIDIA (NVDA), Alibaba Group (BABA), PayPal (PYPL), Netflix (NFLX), Micron Technology (MU), Advanced Micro Devices (AMD), Arista Networks (ANET), Activision Blizzard (ATVI), Block (SQ) and Walt Disney (DIS).

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.54%), Vanguard Group Inc. (9.19%), Bank of New York Mellon Corp (6.59%), State Street Corp (3.23%), Alliancebernstein L.P. (2.97%) and Lazard Asset Management LLC (2.52%). Insiders that own company stock include Anthony Sun, Carl Gerst, Dianne M Parrotte, Eugene G Banucci, Jerry A Schneider, Jerry A Schneider, Patrick Alias, Paul Todgham, Robert Willett, Sheila Marie Dipalma and Theodor Krantz.
View institutional ownership trends.

Shares of CGNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CGNX stock can currently be purchased for approximately $50.76.

Cognex (NASDAQ:CGNX) has a market capitalization of $8.78 billion and generates $1.04 billion in revenue each year. The scientific and technical instruments company earns $279.88 million in net income (profit) each year or $1.21 on an earnings per share basis.

The company employs 2,257 workers across the globe.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The official website for the company is www.cognex.com. The scientific and technical instruments company can be reached via phone at (508) 650-3000, via email at susan.conway@cognex.com, or via fax at 508-650-3333.